4//SEC Filing
SMITH DEVYN 4
Accession 0001415889-21-000691
CIK 0001821323other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:00 AM ET
Size
5.5 KB
Accession
0001415889-21-000691
Insider Transaction Report
Form 4
SMITH DEVYN
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-11+95,000→ 95,000 totalExercise: $39.81Exp: 2031-02-10→ Common Stock (95,000 underlying)
Footnotes (1)
- [F1]The option vest as to 25% of the underlying shares of common stock on February 11, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001833551
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 8:00 AM ET
- Size
- 5.5 KB